| Pharmacogenomics knowledge for personalized medicine M Whirl‐Carrillo, EM McDonagh, JM Hebert, L Gong, K Sangkuhl, ... Clinical Pharmacology & Therapeutics 92 (4), 414-417, 2012 | 2034 | 2012 |
| Clinical assessment incorporating a personal genome EA Ashley, AJ Butte, MT Wheeler, R Chen, TE Klein, FE Dewey, ... The Lancet 375 (9725), 1525-1535, 2010 | 803 | 2010 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ... Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011 | 766 | 2011 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ... Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017 | 597 | 2017 |
| Metformin pathways: pharmacokinetics and pharmacodynamics L Gong, S Goswami, KM Giacomini, RB Altman, TE Klein Pharmacogenetics and genomics 22 (11), 820-827, 2012 | 588 | 2012 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, ... Clinical Pharmacology & Therapeutics 96 (4), 423-428, 2014 | 456 | 2014 |
| Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ... Current drug metabolism 15 (2), 209-217, 2014 | 431 | 2014 |
| An evidence‐based framework for evaluating pharmacogenomics knowledge for personalized medicine M Whirl‐Carrillo, R Huddart, L Gong, K Sangkuhl, CF Thorn, R Whaley, ... Clinical Pharmacology & Therapeutics 110 (3), 563-572, 2021 | 363 | 2021 |
| The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy RA Wilke, LB Ramsey, SG Johnson, WD Maxwell, HL McLeod, D Voora, ... Clinical Pharmacology & Therapeutics 92 (1), 112-117, 2012 | 360 | 2012 |
| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs KN Theken, CR Lee, L Gong, KE Caudle, CM Formea, A Gaedigk, ... Clinical Pharmacology & Therapeutics 108 (2), 191-200, 2020 | 255 | 2020 |
| Celecoxib pathways: pharmacokinetics and pharmacodynamics L Gong, CF Thorn, MM Bertagnolli, T Grosser, RB Altman, TE Klein Pharmacogenetics and genomics 22 (4), 310-318, 2012 | 211 | 2012 |
| CYP2D6 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations MA Province, MP Goetz, H Brauch, DA Flockhart, JM Hebert, R Whaley, ... Clinical Pharmacology & Therapeutics 95 (2), 216-227, 2014 | 200 | 2014 |
| PharmGKB summary: ibuprofen pathways LL Mazaleuskaya, KN Theken, L Gong, CF Thorn, GA FitzGerald, ... Pharmacogenetics and genomics 25 (2), 96-106, 2015 | 185 | 2015 |
| Phased whole-genome genetic risk in a family quartet using a major allele reference sequence FE Dewey, R Chen, SP Cordero, KE Ormond, C Caleshu, KJ Karczewski, ... PLoS genetics 7 (9), e1002280, 2011 | 159 | 2011 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy Z Desta, RS Gammal, L Gong, M Whirl‐Carrillo, AH Gaur, C Sukasem, ... Clinical Pharmacology & Therapeutics 106 (4), 726-733, 2019 | 153 | 2019 |
| VKORC1 pharmacogenomics summary RP Owen, L Gong, H Sagreiya, TE Klein, RB Altman Pharmacogenetics and genomics 20 (10), 642-644, 2010 | 152 | 2010 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal … RM Cooper‐DeHoff, M Niemi, LB Ramsey, JA Luzum, EK Tarkiainen, ... Clinical Pharmacology & Therapeutics 111 (5), 1007-1021, 2022 | 146 | 2022 |
| PharmGKB summary: tramadol pathway L Gong, UM Stamer, MV Tzvetkov, RB Altman, TE Klein Pharmacogenetics and genomics 24 (7), 374-380, 2014 | 123 | 2014 |
| The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge T Hernandez-Boussard, M Whirl-Carrillo, JM Hebert, L Gong, R Owen, ... Nucleic acids research 36 (suppl_1), D913-D918, 2007 | 122 | 2007 |
| Very important pharmacogene summary ADRB2 AA Litonjua, L Gong, QL Duan, J Shin, MJ Moore, ST Weiss, JA Johnson, ... Pharmacogenetics and genomics 20 (1), 64-69, 2010 | 116 | 2010 |
